A formulation of MSD's cancer drug Keytruda that can be given by subcutaneous injection rather than intravenous infusion has cleared a phase 3 trial, setting up approvals later this year. The ...

We've been to school. We know how education works. Right? In fact, many aspects of learning — in homes, at schools, at work and elsewhere — are evolving rapidly, along with our understanding ...